Hampel Howard, Abraham Neena S, El-Serag Hashem B
Michael E. DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, Texas 77030, USA.
Ann Intern Med. 2005 Aug 2;143(3):199-211. doi: 10.7326/0003-4819-143-3-200508020-00006.
The association of body mass index and gastroesophageal reflux disease (GERD), including its complications (esophagitis, Barrett esophagus, and esophageal adenocarcinoma), is unclear.
To conduct a systematic review and meta-analysis to estimate the magnitude and determinants of an association between obesity and GERD symptoms, erosive esophagitis, Barrett esophagus, and adenocarcinoma of the esophagus and of the gastric cardia.
MEDLINE search between 1966 and October 2004 for published full studies.
Studies that provided risk estimates and met criteria on defining exposure and reporting outcomes and sample size.
Two investigators independently performed standardized search and data abstraction. Unadjusted and adjusted odds ratios for individual outcomes were obtained or calculated for each study and were pooled by using a random-effects model.
Nine studies examined the association of body mass index (BMI) with GERD symptoms. Six of these studies found statistically significant associations. Six of 7 studies found significant associations of BMI with erosive esophagitis, 6 of 7 found significant associations with esophageal adenocarcinoma, and 4 of 6 found significant associations with gastric cardia adenocarcinoma. In data from 8 studies, there was a trend toward a dose-response relationship with an increase in the pooled adjusted odds ratios for GERD symptoms of 1.43 (95% CI, 1.158 to 1.774) for BMI of 25 kg/m2 to 30 kg/m2 and 1.94 (CI, 1.468 to 2.566) for BMI greater than 30 kg/m2. Similarly, the pooled adjusted odds ratios for esophageal adenocarcinoma for BMI of 25 kg/m2 to 30 kg/m2 and BMI greater than 30 kg/m2 were 1.52 (CI, 1.147 to 2.009) and 2.78 (CI, 1.850 to 4.164), respectively.
Heterogeneity in the findings was present, although it was mostly in the magnitude of statistically significant positive associations. No studies in this review examined the association between Barrett esophagus and obesity.
Obesity is associated with a statistically significant increase in the risk for GERD symptoms, erosive esophagitis, and esophageal adenocarcinoma. The risk for these disorders seems to progressively increase with increasing weight.
体重指数与胃食管反流病(GERD)及其并发症(食管炎、巴雷特食管和食管腺癌)之间的关联尚不清楚。
进行一项系统评价和荟萃分析,以评估肥胖与GERD症状、糜烂性食管炎、巴雷特食管以及食管和贲门腺癌之间关联的程度和决定因素。
检索1966年至2004年10月期间MEDLINE上发表的完整研究。
提供风险估计且符合定义暴露、报告结局和样本量标准的研究。
两名研究人员独立进行标准化检索和数据提取。为每项研究获取或计算个体结局的未调整和调整后的比值比,并使用随机效应模型进行汇总。
九项研究探讨了体重指数(BMI)与GERD症状之间的关联。其中六项研究发现具有统计学意义的关联。七项研究中有六项发现BMI与糜烂性食管炎存在显著关联,七项中有六项发现与食管腺癌存在显著关联,六项中有四项发现与贲门腺癌存在显著关联。在八项研究的数据中,存在剂量反应关系趋势,BMI为25kg/m²至30kg/m²时,GERD症状的汇总调整后比值比增加1.43(95%CI,1.158至1.774),BMI大于30kg/m²时为1.94(CI,1.468至2.566)。同样,BMI为25kg/m²至30kg/m²和大于30kg/m²时,食管腺癌的汇总调整后比值比分别为1.52(CI,1.147至2.009)和2.78(CI,1.850至4.164)。
研究结果存在异质性,尽管主要体现在具有统计学意义的正相关的程度上。本综述中没有研究探讨巴雷特食管与肥胖之间的关联。
肥胖与GERD症状、糜烂性食管炎和食管腺癌的风险在统计学上显著增加相关。这些疾病的风险似乎随着体重增加而逐渐升高。